The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases
Open accessAbstract
Liposomes are closed bilayer structures spontaneously formed by hydrated phospholipids that are widely used as efficient delivery systems for drugs or antigens, due to their capability to encapsulate bioactive hydrophilic, amphipathic, and lipophilic molecules into inner water phase or within lipid leaflets. The efficacy of liposomes as drug or antigen carriers has been improved in the last years to ameliorate pharmacokinetics and capacity to release their cargo in selected target organs or cells. Moreover, different formulations and variations in liposome composition have been often proposed to include immunostimulatory molecules, ligands for specific receptors, or stimuli responsive compounds. Intriguingly, independent research has unveiled the capacity of several phospholipids to play critical roles as intracellular messengers in modulating both innate and adaptive immune responses through various mechanisms, including (i) activation of different antimicrobial enzymatic pathways, (ii) driving the fusion-fission events between endosomes with direct consequences to phagosome maturation and/or to antigen presentation pathway, and (iii) modulation of the inflammatory response. These features can be exploited by including selected bioactive phospholipids in the bilayer scaffold of liposomes. This would represent an important step forward since drug or antigen carrying liposomes could be engineered to simultaneously activate different signal transduction pathways and target specific cells or tissues to induce antigen-specific T and/or B cell response. This lipid-based host-directed strategy can provide a focused antimicrobial innate and adaptive immune response against specific pathogens and offer a novel prophylactic or therapeutic option against chronic, recurrent, or drug-resistant infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · cited 6×
“The improvements in the therapeutic outcomes of stealth liposomes in comparison with conventional ULV for a variety of therapeutics was demonstrated in different animal models of disease (26), and then in the humans, where the long circulation half-life of a doxorubicin entrapped in PEG–liposomes was confirmed.”
BackgroundMethodInfluentialDiffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · cited 1×
“Within a few years after the first description of “swollen phospholipid systems” by Bangham and colleagues (20), various enclosed phospholipid structures consisting of single bilayers, initially termed “banghaosomes” and then “liposomes” (21), were described (22).”
BackgroundPhosphoinositides in cell regulation and membrane dynamics
Di Paolo, G., & De Camilli, P. (2006) · Nature · doi:10.1038/nature05185 · Cited by 2,790
Liposomes as nanomedical devices
Bozzuto, G., & Molinari, A. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s68861 · Cited by 2,261
Membrane curvature and mechanisms of dynamic cell membrane remodelling
McMahon, H. T., & Gallop, J. L. (2005) · Nature · doi:10.1038/nature04396 · Cited by 2,163
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Effect of Chain Length and Unsaturation on Elasticity of Lipid Bilayers
Rawicz, W., Olbrich, K. C., McIntosh, T., Needham, D., & Evans, E. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76295-3 · Cited by 1,932
Cross-presentation by dendritic cells
Joffre, O. P., Segura, E., Savina, A., & Amigorena, S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3254 · Cited by 1,637
Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., & Redemann, C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,620
Single bilayer liposomes prepared without sonication
Batzri, S., & Korn, E. D. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90408-2 · Cited by 1,358
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
Nanoparticles target distinct dendritic cell populations according to their size
Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737984 · Cited by 1,289
Abuchowski, A., McCoy, J. R., Palczuk, N. C., van Es, T., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,274
Wang-Gillam, A., Li, C.-P., Bodoky, G., Dean, A., Shan, Y.-S., Jameson, G., Macarulla, T., Lee, K.-H., Cunningham, D., Blanc, J. F., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00986-1 · Cited by 1,222 · cited 1×
“OnivydeTM Irinotecan Multilamellar vesicles Metastatic adenocarcinoma of the pancreas (48)”
BackgroundmRNA is an endogenous ligand for toll-like receptor 3
Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062
Antimicrobial mechanisms of phagocytes and bacterial evasion strategies
Flannagan, R. S., Cosío, G., & Grinstein, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2128 · Cited by 947
Modified mRNA vaccines protect against zika virus infection
Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909
Getting Across the Cell Membrane: An Overview for Small Molecules, Peptides, and Proteins
Yang, N. J., & Hinner, M. J. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2272-7_3 · Cited by 826
PI(3,4,5)P 3 and PI(4,5)P 2 Lipids Target Proteins with Polybasic Clusters to the Plasma Membrane
Heo, W. D., Inoue, T., Park, W. S., Kim, M. L., Park, B. O., Wandless, T. J., & Meyer, T. (2006) · Science · doi:10.1126/science.1134389 · Cited by 775
Meyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., Betcher, D., Ferguson, W. S., Gebhardt, M. C., Goorin, A. M., Harris, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.14.0095 · Cited by 752
Agrawal, S., Agrawal, A., Doughty, B., Gerwitz, A., Blenis, J., Van Dyke, T., & Pulendran, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.4984 · Cited by 725
Role of LBPA and Alix in Multivesicular Liposome Formation and Endosome Organization
Matsuo, H., Chevallier, J., Mayran, N., Le Blanc, I., Ferguson, C., Fauré, J., Blanc, N. S., Matile, S., Dubochet, J., Sadoul, R., et al. (2004) · Science · doi:10.1126/science.1092425 · Cited by 705
Liposomes as immunological adjuvants
ALLISON, A. C., & GREGORIADIS, G. (1974) · Nature · doi:10.1038/252252a0 · Cited by 675
Ford, M. G. J., Pearse, B. M. F., Higgins, M. K., Vallis, Y., Owen, D. J., Gibson, A., Hopkins, C. R., Evans, P. R., & McMahon, H. T. (2001) · Science · doi:10.1126/science.291.5506.1051 · Cited by 659
The PX domains of p47phox and p40phox bind to lipid products of PI(3)K
Kanai, F., Liu, H., Field, S. J., Akbary, H., Matsuo, T., Brown, G. E., Cantley, L. C., & Yaffe, M. B. (2001) · Nature Cell Biology · doi:10.1038/35083070 · Cited by 611
The Carrier Potential of Liposomes in Biology and Medicine: (First of Two Parts)
Gregoriadis, G. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609232951305 · Cited by 595
Pharmacokinetics of stealth versus conventional liposomes: effect of dose
Allen, T. M., & Hansen, C. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90201-i · Cited by 579
Schmid, D., Pypaert, M., & Münz, C. (2007) · Immunity · doi:10.1016/j.immuni.2006.10.018 · Cited by 577
Specific and high-affinity binding of inositol phosphates to an isolated pleckstrin homology domain
Lemmon, M. A., Ferguson, K. M., O'Brien, R., Sigler, P. B., & Schlessinger, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10472 · Cited by 566
Activation of phospholipase Cgamma by PI 3-kinase-induced PH domain-mediated membrane targeting
Falasca, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.414 · Cited by 564
Phosphoinositide Recognition Domains
Lemmon, M. A. (2003) · Traffic · doi:10.1034/j.1600-0854.2004.00071.x · Cited by 563
Peetla, C., Stine, A., & Labhasetwar, V. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9000662 · Cited by 559
Gaullier, J.-M., Simonsen, A., D'Arrigo, A., Bremnes, B., Stenmark, H., & Aasland, R. (1998) · Nature · doi:10.1038/28767 · Cited by 553
Innate immunity in tuberculosis: host defense vs pathogen evasion
Liu, C. H., Liu, H., & Ge, B. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2017.88 · Cited by 532
Liposomes as vaccine delivery systems: a review of the recent advances
Schwendener, R. A. (2014) · Therapeutic Advances in Vaccines · doi:10.1177/2051013614541440 · Cited by 525
Miller, C. R., Bondurant, B., McLean, S. D., McGovern, K. A., & O'Brien, D. F. (1998) · Biochemistry · doi:10.1021/bi980096y · Cited by 524
Activated CD4+CD25+ T cells selectively kill B lymphocytes
Zhao, D.-M., Thornton, A. M., DiPaolo, R. J., & Shevach, E. M. (2006) · Blood · doi:10.1182/blood-2005-11-4502 · Cited by 506
Levine, T. P., & Munro, S. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00779-0 · Cited by 493
CFTR regulates phagosome acidification in macrophages and alters bactericidal activity
Di, A., Brown, M. E., Deriy, L. V., Li, C., Szeto, F. L., Chen, Y., Huang, P., Tong, J., Naren, A. P., Bindokas, V., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1456 · Cited by 492
Gozani, O., Karuman, P., Jones, D. R., Ivanov, D., Cha, J., Lugovskoy, A. A., Baird, C. L., Zhu, H., Field, S. J., Lessnick, S. L., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00480-x · Cited by 489
Uziely, B., Jeffers, S., Isacson, R., Kutsch, K., Wei-Tsao, D., Yehoshua, Z., Libson, E., Muggia, F. M., & Gabizon, A. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1777 · Cited by 477
Role of the ENTH Domain in Phosphatidylinositol-4,5-Bisphosphate Binding and Endocytosis
Itoh, T., Koshiba, S., Kigawa, T., Kikuchi, A., Yokoyama, S., & Takenawa, T. (2001) · Science · doi:10.1126/science.291.5506.1047 · Cited by 469
Mechanisms of Membrane Curvature Sensing
Antonny, B. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052809-155121 · Cited by 430
Stimuli-responsive nanomaterials for therapeutic protein delivery
Lu, Y., Sun, W., & Gu, Z. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.015 · Cited by 415
A requirement for phosphatidylinositol 3-kinase in pseudopod extension
Cox, D., Tseng, C.-C., Bjekic, G., & Greenberg, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1240 · Cited by 410
Jenkins, G. H., Fisette, P. L., & Anderson, R. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78159-9 · Cited by 406
Lopez-Berestein, G., Fainstein, V., Hopfer, R., Mehta, K., Sullivan, M. P., Keating, M., Rosenblum, M. G., Mehta, R., Luna, M., Hersh, E. M., et al. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.4.704 · Cited by 405
Modulation of Membrane Curvature by Phosphatidic Acid and Lysophosphatidic Acid
Kooijman, E. E., Chupin, V., de Kruijff, B., & Burger, K. N. J. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00086.x · Cited by 403
Zumla, A., Rao, M., Wallis, R. S., Kaufmann, S. H. E., Rustomjee, R., Mwaba, P., Vilaplana, C., Yeboah-Manu, D., Chakaya, J., Ippolito, G., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00078-5 · Cited by 402
Liang, F., Lindgren, G., Lin, A., Thompson, E. A., Ols, S., Röhss, J., John, S., Hassett, K., Yuzhakov, O., Bahl, K., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.08.006 · Cited by 395
Apoptotic Vesicles Crossprime CD8 T Cells and Protect against Tuberculosis
Winau, F., Weber, S., Sad, S., de Diego, J., Hoops, S. L., Breiden, B., Sandhoff, K., Brinkmann, V., Kaufmann, S. H. E., & Schaible, U. E. (2006) · Immunity · doi:10.1016/j.immuni.2005.12.001 · Cited by 395
Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination
Desmet, C. J., & Ishii, K. J. (2012) · Nature Reviews Immunology · doi:10.1038/nri3247 · Cited by 392
Liposomal Delivery Systems: Design Optimization and Current Applications
Abu Lila, A. S., & Ishida, T. (2017) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00624 · Cited by 382
Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain
Hamada, K. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4449 · Cited by 377
Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA
Chen, S., Tam, Y. Y. C., Lin, P. J. C., Sung, M. M. H., Tam, Y. K., & Cullis, P. R. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.059 · Cited by 366
Vergne, I., Chua, J., & Deretic, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030527 · Cited by 354
AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience
Adler-Moore, J., & Proffitt, R. T. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.21 · Cited by 339
Watson, D. S., Endsley, A. N., & Huang, L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.070 · Cited by 322
The Carrier Potential of Liposomes in Biology and Medicine: (Second of Two Parts)
Gregoriadis, G. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609302951406 · Cited by 321
Pandey, R., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2004.11.003 · Cited by 318
The life cycle of phagosomes: formation, maturation, and resolution
Levin, R., Grinstein, S., & Canton, J. (2016) · Immunological Reviews · doi:10.1111/imr.12439 · Cited by 317
Werninghaus, K., Babiak, A., Groß, O., Hölscher, C., Dietrich, H., Agger, E. M., Mages, J., Mocsai, A., Schoenen, H., Finger, K., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081445 · Cited by 315
Role of Phospholipids in Endocytosis, Phagocytosis, and Macropinocytosis
Bohdanowicz, M., & Grinstein, S. (2013) · Physiological Reviews · doi:10.1152/physrev.00002.2012 · Cited by 311
Karathanassis, D., Stahelin, R. V., Bravo, J., Perisic, O., Pacold, C. M., Cho, W., & Williams, R. L. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf519 · Cited by 294
Weber, S. S., Ragaz, C., Reus, K., Nyfeler, Y., & Hilbi, H. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020046 · Cited by 292
Phosphatidylinositol 4,5-bisphosphate clusters act as molecular beacons for vesicle recruitment
Honigmann, A., van den Bogaart, G., Iraheta, E., Risselada, H. J., Milovanovic, D., Mueller, V., Müllar, S., Diederichsen, U., Fasshauer, D., Grubmüller, H., et al. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2570 · Cited by 279
Anes, E., Kühnel, M. P., Bos, E., Moniz-Pereira, J., Habermann, A., & Griffiths, G. (2003) · Nature Cell Biology · doi:10.1038/ncb1036 · Cited by 278
Pharmaceutical product development: A quality by design approach
Ali, J., Pramod, K., Tahir, M., Charoo, N., & Ansari, S. (2016) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.187350 · Cited by 249
Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome
Yang, T., Choi, M.-K., Cui, F.-D., Kim, J. S., Chung, S.-J., Shim, C.-K., & Kim, D.-D. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.011 · Cited by 245
Shiose, A., & Sumimoto, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13793 · Cited by 243
Immunological Consequences of Apoptotic Cell Phagocytosis
Erwig, L.-P., & Henson, P. M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070135 · Cited by 242 · cited 1×
“These features have been previously reported as a possible therapeutic strategy to reduce immunopathologic responses (136, 140).”
BackgroundManjappa, A. S., Chaudhari, K. R., Venkataraju, M. P., Dantuluri, P., Nanda, B., Sidda, C., Sawant, K. K., & Ramachandra Murthy, R. S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.002 · Cited by 236
A Review on Composite Liposomal Technologies for Specialized Drug Delivery
Mufamadi, M. S., Pillay, V., Choonara, Y. E., Du Toit, L. C., Modi, G., Naidoo, D., & Ndesendo, V. M. K. (2011) · Journal of Drug Delivery · doi:10.1155/2011/939851 · Cited by 229
Rapidly produced SAM ® vaccine against H7N9 influenza is immunogenic in mice
Hekele, A., Bertholet, S., Archer, J., Gibson, D. G., Palladino, G., Brito, L. A., Otten, G. R., Brazzoli, M., Buccato, S., Bonci, A., et al. (2013) · Emerging Microbes & Infections · doi:10.1038/emi.2013.54 · Cited by 226
EpsinR: an ENTH Domain-containing Protein that Interacts with AP-1
Hirst, J., Motley, A., Harasaki, K., Peak Chew, S. Y., & Robinson, M. S. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-09-0552 · Cited by 216
Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia
Li, L., ten Hagen, T. L. M., Schipper, D., Wijnberg, T. M., van Rhoon, G. C., Eggermont, A. M. M., Lindner, L. H., & Koning, G. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.006 · Cited by 214
Tandrup Schmidt, S., Foged, C., Smith Korsholm, K., Rades, T., & Christensen, D. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics8010007 · Cited by 213
Spragg, D. D., Alford, D. R., Greferath, R., Larsen, C. E., Lee, K.-D., Gurtner, G. C., Cybulsky, M. I., Tosi, P. F., Nicolau, C., & Gimbrone, M. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8795 · Cited by 212
Hoffmann, P. R., Kench, J. A., Vondracek, A., Kruk, E., Daleke, D. L., Jordan, M., Marrack, P., Henson, P. M., & Fadok, V. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1393 · Cited by 210
Immunoliposomes: A review on functionalization strategies and targets for drug delivery
Eloy, J. O., Petrilli, R., Trevizan, L. N. F., & Chorilli, M. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2017.07.085 · Cited by 209
Phosphatidylinositol 3,5-bisphosphate and Fab1p/PIKfyve underPPIn endo-lysosome function
Dove, S. K., Dong, K., Kobayashi, T., Williams, F. K., & Michell, R. H. (2009) · Biochemical Journal · doi:10.1042/bj20081950 · Cited by 208
Malik, Z. A., Thompson, C. R., Hashimi, S., Porter, B., Iyer, S. S., & Kusner, D. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.2811 · Cited by 208
Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition
Foged, C., Arigita, C., Sundblad, A., Jiskoot, W., Storm, G., & Frokjaer, S. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.11.008 · Cited by 206
Liposomal doxorubicin (Doxil): An effective new treatment for Kaposi's sarcoma in AIDS
James, N. D., Coker, R. J., Tomlinson, D., Harris, J. R. W., Gompels, M., Pinching, A. J., & Stewart, J. S. W. (1994) · Clinical Oncology · doi:10.1016/s0936-6555(05)80269-9 · Cited by 205
Antitubercular inhaled therapy: opportunities, progress and challenges
Pandey, R., & Khuller, G. K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki027 · Cited by 188
Pulmonary drug delivery systems for tuberculosis treatment
Pham, D.-D., Fattal, E., & Tsapis, N. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.009 · Cited by 185
Lipid signaling and the modulation of surface charge during phagocytosis
Yeung, T., & Grinstein, S. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00546.x · Cited by 181
Bogers, W. M., Oostermeijer, H., Mooij, P., Koopman, G., Verschoor, E. J., Davis, D., Ulmer, J. B., Brito, L. A., Cu, Y., Banerjee, K., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu522 · Cited by 181
Brito, L. A., Kommareddy, S., Maione, D., Uematsu, Y., Giovani, C., Berlanda Scorza, F., Otten, G. R., Yu, D., Mandl, C. W., Mason, P. W., et al. (2015) · Advances in Genetics · doi:10.1016/bs.adgen.2014.10.005 · Cited by 181
Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages
Lee, W.-H., Loo, C.-Y., Traini, D., & Young, P. M. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1039509 · Cited by 179
Henriksen‐Lacey, M., Christensen, D., Bramwell, V. W., Lindenstrøm, T., Agger, E. M., Andersen, P. L., & Perrie, Y. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.027 · Cited by 175
Mann, J. F. S., Shakir, E., Carter, K. C., Mullen, A. B., Alexander, J., & Ferro, V. A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.040 · Cited by 166
Manipulation of host membranes by bacterial effectors
Ham, H., Sreelatha, A., & Orth, K. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2602 · Cited by 165
Tsujita, K., Itoh, T., Ijuin, T., Yamamoto, A., Shisheva, A., Laporte, J., & Takenawa, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312294200 · Cited by 165
Phosphoinositides in phagocytosis and macropinocytosis
Levin‐Konigsberg, R., Grinstein, S., & Schlam, D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.005 · Cited by 164
Rawal, T., Parmar, R., Tyagi, R. K., & Butani, S. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2017.03.044 · Cited by 162
Harding, C. V., Collins, D. S., Kanagawa, O., & Unanue, E. R. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.9.2860 · Cited by 161
Zehner, M., Marschall, A. L., Bos, E., Schloetel, J.-G., Kreer, C., Fehrenschild, D., Limmer, A., Ossendorp, F., Lang, T., Koster, A. J., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.008 · Cited by 160
Innate apoptotic immunity: the calming touch of death
Birge, R. B., & Ucker, D. S. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.58 · Cited by 158
Damen, J., Regts, J., & Scherphof, G. L. (1981) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(81)90268-x · Cited by 155
Manna, D., Albanese, A., Park, W. S., & Cho, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703517200 · Cited by 154
Lipid Vesicle Size Determines the Th1 or Th2 Response to Entrapped Antigen
Brewer, J. M., Tetley, L., Richmond, J. A., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.4000 · Cited by 154
Extended CSF cytarabine exposure following intrathecal administration of DTC 101.
Kim, S., Chatelut, É., Kim, J. C., et al. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.11.2186 · Cited by 153
Emerging roles of liposomal bupivacaine in anesthesia practice
Urman, R., Malik, O. S., Kaye, A., Kaye, A. J., & Belani, K. G. (2017) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/joacp.joacp_375_15 · Cited by 151
Yeung, T., Heit, B., Dubuisson, J.-F., Fairn, G. D., Chiu, B., Inman, R. D., Kapùs, A., Swanson, M. S., & Grinstein, S. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200903020 · Cited by 147
Designing liposomal adjuvants for the next generation of vaccines
Perrie, Y., Crofts, F., Devitt, A., Griffiths, H. R., Kastner, E., & Nadella, V. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.005 · Cited by 140
Subversion of Phagocytosis for Pathogen Survival
Sarantis, H., & Grinstein, S. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.09.001 · Cited by 138
Vesicle Size Influences the Trafficking, Processing, and Presentation of Antigens in Lipid Vesicles
Brewer, J. M., Pollock, K. G. J., Tetley, L., & Russell, D. G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6143 · Cited by 135
Synthesis of Cetuximab-Immunoliposomes via a Cholesterol-Based Membrane Anchor for Targeting of EGFR
Pan, X., Wu, G. J., Yang, W., Barth, R. F., Tjarks, W., & Lee, R. J. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060174r · Cited by 134
Respirable nanocarriers as a promising strategy for antitubercular drug delivery
Mehanna, M. M., Mohyeldin, S. M., & Elgindy, N. A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.038 · Cited by 132
Isoniazid Proliposome Powders for Inhalation—Preparation, Characterization and Cell Culture Studies
Rojanarat, W., Changsan, N., Tawithong, E., Pinsuwan, S., Chan, H., & Srichana, T. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12074414 · Cited by 130
Nucleoside modified mRNA vaccines for infectious diseases
Pardi, N., & Weissman, D. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6481-9_6 · Cited by 129
From “Banghasomes” to liposomes: A memoir of Alec Bangham, 1921–2010
Deamer, D. W. (2010) · The FASEB Journal · doi:10.1096/fj.10-0503 · Cited by 129
Krishna, R., Webb, M. S., St.-Onge, G., & Mayer, L. D. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29494-5 · Cited by 129
Islam, P., Water, J. J., Bohr, A., & Rantanen, J. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics9010001 · Cited by 127
Phosphatidic acid is required for the constitutive ruffling and macropinocytosis of phagocytes
Bohdanowicz, M., Schlam, D., Hermansson, M., Rizzuti, D., Fairn, G. D., Ueyama, T., Somerharju, P. J., Du, G., & Grinstein, S. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-11-0789 · Cited by 126
Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines
Alving, C. R., Rao, M., Steers, N. J., Matyas, G. R., & Mayorov, A. V. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.35 · Cited by 122
Overview and Historical Perspectives
Kaper, J. B., & O’Brien, A. D. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.ehec-0028-2014 · Cited by 119
Evasion of Innate and Adaptive Immunity by Mycobacterium tuberculosis
Goldberg, M. F., Saini, N. K., & Porcelli, S. A. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mgm2-0005-2013 · Cited by 118
Liposome-Based Delivery System for Vaccine Candidates: Constructing An Effective Formulation
Giddam, A. K., Zaman, M., Skwarczyński, M., & Tóth, I. (2012) · Nanomedicine · doi:10.2217/nnm.12.157 · Cited by 117
Stolt, P. C., Jeon, H., Song, H. K., Herz, J., Eck, M. J., & Blacklow, S. C. (2003) · Structure · doi:10.1016/s0969-2126(03)00068-6 · Cited by 117
Nakanishi, T., Kunisawa, J., Hayashi, A., Tsutsumi, Y. M., Kubo, K., Nakagawa, S., Fujiwara, H., Hamaoka, T., & Mayumi, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7749 · Cited by 114
Christensen, D., Henriksen‐Lacey, M., Kamath, A. T., Lindenstrøm, T., Korsholm, K. S., Christensen, J. P., Rochat, A., Lambert, P., Andersen, P. L., Siegrist, C., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.016 · Cited by 113
Korsholm, K. S., Hansen, J. U., Karlsen, K. K., Filskov, J., Mikkelsen, M., Lindenstrøm, T., Schmidt, S., Andersen, P. L., & Christensen, D. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.05.050 · Cited by 112
Reddy, R., Zhou, F., Huang, L., Carbone, F., Bevan, M. J., & Rouse, B. T. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90142-3 · Cited by 112
Mucosal Vaccine Development Based on Liposome Technology
Bernasconi, V., Norling, K., Bally, M., Höök, F., & Lycke, N. Y. (2016) · Journal of Immunology Research · doi:10.1155/2016/5482087 · Cited by 112
Lipid metabolism and dynamics during phagocytosis
Yeung, T., Ozdamar, B., Paroutis, P., & Grinstein, S. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.06.006 · Cited by 109
Ludewig, B., Barchiesi, F., Pericin, M., Zinkernagel, R. M., Hengartner, H., & Schwendener, R. A. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00163-8 · Cited by 108
Zumla, A. I., Memish, Z. A., Maeurer, M. J., Bates, M., Mwaba, P., Al‐Tawfiq, J. A., Denning, D. W., Hayden, F. G., & Hui, D. S. C. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70828-x · Cited by 108
Liposomes as Immunological Adjuvants
ALLISON, A. C., & Gregoriadis, G. (1976) · Springer eBooks · doi:10.1007/978-3-642-81049-7_8 · Cited by 104
Chua, J., & Deretic, V. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405082200 · Cited by 103
Steinberg, B. E., & Grinstein, S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35433 · Cited by 103
Liu, L., Ma, P., Wang, H., Zhang, C., Sun, H., Wang, C., Song, C. X., Leng, X., Kong, D., & Ma, G. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.050 · Cited by 103
Zakrewsky, M., Kumar, S., & Mitragotri, S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.017 · Cited by 99
Corbalán‐García, S., García-García, J., Rodríguez-Alfaro, J. A., & Gómez-Fernández, J. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209385200 · Cited by 99
Bal, S. M., Hortensius, S., Ding, Z., Jiskoot, W., & Bouwstra, J. A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.061 · Cited by 97
Eugster, A., Pécheur, E., Michel, F., Winsor, B., Letourneur, F., & Friant, S. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-11-0793 · Cited by 97
Michot, J.-M., Seral, C., Françoise Van Bambeke, A., Mingeot‐Leclercq, M., & Tulkens, P. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2429-2437.2005 · Cited by 97
Wong, D., Chao, J. D., & Av‐Gay, Y. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.09.002 · Cited by 96
Patil-Gadhe, A., & Pokharkar, V. (2013) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2013.07.006 · Cited by 91
Richards, R. L., Rao, M., Wassef, N. M., Glenn, G. M., Rothwell, S. W., & Alving, C. R. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2859-2865.1998 · Cited by 91
Gao, J., Ochyl, L. J., Yang, E., & Moon, J. J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s125866 · Cited by 91
López-Andreo, M. J., Gómez-Fernández, J. C., & Corbalán‐García, S. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-05-0295 · Cited by 90
Bensikaddour, H., Snoussi, K., Lins, L., Françoise Van Bambeke, A., Tulkens, P. M., Brasseur, R., Goormaghtigh, E., & Mingeot‐Leclercq, M. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.08.015 · Cited by 86
Liposome-Based Immunotherapy Against Autoimmune Diseases: Therapeutic Effect on Multiple Sclerosis
Pujol‐Autonell, I., Mansilla, M. J., Rodríguez-Fernández, S., Cano‐Sarabia, M., Navarro‐Barriuso, J., Ampudia, R.-M., Rius, A., García‐Jimeno, S., Perna‐Barrull, D., Martínez-Cáceres, E. M., et al. (2017) · Nanomedicine · doi:10.2217/nnm-2016-0410 · Cited by 84
Sphingosine 1–Phosphate Induces Antimicrobial Activity Both In Vitro and In Vivo
Garg, S. K., Volpe, E., Palmieri, G., Mattei, M., Galati, D., Martino, A., Piccioni, M. S., Valente, E., Bonanno, E., Vito, P. D., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/386286 · Cited by 83
Self-citationInhaled pyrazinamide proliposome for targeting alveolar macrophages
Rojanarat, W., Nakpheng, T., Thawithong, E., Yanyium, N., & Srichana, T. (2012) · Drug Delivery · doi:10.3109/10717544.2012.721144 · Cited by 83
TOM1 is a PI5P effector involved in the regulation of endosomal maturation
Boal, F., Mansour, R., Gayral, M., Saland, E., Chicanne, G., Xuereb, J.-M., Marcellin, M., Burlet‐Schiltz, O., Sansonetti, P. J., Payrastre, B., et al. (2015) · Journal of Cell Science · doi:10.1242/jcs.166314 · Cited by 83
Douer, D. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0391 · Cited by 83
LISTER, J. W. (1996) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1996.tb01348.x · Cited by 81
Matyas, G. R., Mayorov, A. V., Rice, K. C., Jacobson, A. E., Cheng, K., Iyer, M. R., Li, F., Beck, Z., Janda, K. D., & Alving, C. R. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.04.027 · Cited by 81
Dry powder inhalable formulations for anti-tubercular therapy
Parumasivam, T., Chang, R. Y. K., Abdelghany, S. M., Ye, T. T., Britton, W. J., & Chan, H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.011 · Cited by 81
Phospholipase D1 and potential targets of its hydrolysis product, phosphatidic acid
Ktistakis, N. T., Delon, C., Manifava, M., Wood, E., Ganley, I. G., & Sugars, J. M. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310094 · Cited by 80
Greco, E., Quintiliani, G., Santucci, M. B., Serafino, A., Ciccaglione, A. R., Marcantonio, C., Papi, M., Maulucci, G., Delogu, G., Martino, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200484109 · Cited by 79
Self-citationInvestigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization
Gupta, P. N., & Vyas, S. P. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.08.027 · Cited by 78
Incorporation of Antibiotics in Liposomes Designed for Tuberculosis Therapy by Inhalation
Justo, O. R., & Moraes, Â. M. (2003) · Drug Delivery · doi:10.1080/713840401 · Cited by 77
Zaru, M., Sinico, C., Logu, A. D., Caddeo, C., Lai, F., Manca, M. L., & Fadda, A. M. (2009) · Journal of Liposome Research · doi:10.1080/08982100802610835 · Cited by 75
Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
Islan, G. A., Durán, M., Cacicedo, M. L., Nakazato, G., Kobayashi, R. K. T., Martinez, D. S. T., Castro, G. R., & Durán, N. (2017) · Acta Tropica · doi:10.1016/j.actatropica.2017.02.019 · Cited by 70
Taneichi, M., Ishida, H., Kajino, K., Ogasawara, K., Tanaka, Y., Kasai, M., Mori, M., Nishida, M., Yamamura, H., Mizuguchi, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2324 · Cited by 66
Infection and apoptosis as a combined inflammatory trigger
Torchinsky, M. B., Garaude, J., & Blander, J. M. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.003 · Cited by 66
Rajendran, V., Rohra, S., Raza, M., Hasan, G. M., Dutt, S., & Ghosh, P. C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01796-15 · Cited by 65
Moore, N. M., Sheppard, C. L., Barbour, T. R., & Sakiyama‐Elbert, S. E. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1234 · Cited by 63
Lee, J. S., Kim, J. H., Jang, I. H., Kim, H. S., Han, J. M., Kazlauskas, A., Yagisawa, H., Suh, P., & Ryu, S. H. (2005) · Journal of Cell Science · doi:10.1242/jcs.02564 · Cited by 63
Pizarro‐Cerdá, J., Charbit, A., Enninga, J., Lafont, F., & Cossart, P. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.07.019 · Cited by 63
Genito, C. J., Beck, Z., Phares, T. W., Kalle, F., Limbach, K. J., Stefaniak, M. E., Patterson, N. B., Bergmann‐Leitner, E. S., Waters, N. C., Matyas, G. R., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.05.070 · Cited by 59
Ciaramella, A., Cavone, A., Santucci, M. B., Garg, S. K., Sanarico, N., Bocchino, M., Galati, D., Martino, A., Auricchio, G., D’Orazio, M., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/423850 · Cited by 58
Self-citationParumasivam, T., Leung, S. S. Y., Quan, D. H., Triccas, J. A., Britton, W. J., & Chan, H. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.03.024 · Cited by 58
Barnier-Quer, C., Elsharkawy, A., Romeijn, S. G., Kros, A., & Jiskoot, W. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5030392 · Cited by 57
Functional drug targeting to erythrocytes in vivo using antibody bearing liposomes as drug vehicles
Agrawal, A., Singhal, A. K., & Gupta, C. M. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)91118-1 · Cited by 56
Nanotechnology as a potential therapeutic alternative for schistosomiasis
Tomiotto‐Pellissier, F., Miranda-Sapla, M. M., Machado, L. F., Bortoleti, B. T. D. S., Sahd, C. S., Chagas, A. F., Assolini, J. P., de Oliveira, F. J., Pavanelli, W. R., Costa, I. C., et al. (2017) · Acta Tropica · doi:10.1016/j.actatropica.2017.06.025 · Cited by 56
Mašek, J., Bartheldyová, E., Turánek-Knötigová, P., Škrabalová, M., Korvasová, Z., Plocková, J., Koudelka, Š., Škodová, P., Kulich, P., Křupka, M., et al. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.016 · Cited by 54
Tanaka, Y., Taneichi, M., Kasai, M., Kakiuchi, T., & Uchida, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015225 · Cited by 52
Archaeosomes with encapsulated antigens for oral vaccine delivery
Li, Z., Zhang, L., Sun, W., Ding, Q., Hou, Y., & Xu, Y. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.015 · Cited by 50
Introduction to Special Issue: A New Paradigm of Gene Therapy
Itaka, K. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics8010001 · Cited by 50
Shin, M., Snyder, H. W., Donvito, G., Schurman, L. D., Fox, T. E., Lichtman, A. H., KESTER, M. A., & Hsu, K. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00657 · Cited by 50
Kawasaki, N., Rillahan, C. D., Cheng, T., Rhijn, I. V., Macauley, M. S., Moody, D. B., & Paulson, J. C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303278 · Cited by 48
Klauber, T. C. B., Moll, J. M., Zucker, D., Brix, S., Jensen, S. S., & Andresen, T. L. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.072 · Cited by 45
Pang, L., Macauley, M. S., Arlian, B. M., Nycholat, C. M., & Paulson, J. C. (2017) · ChemBioChem · doi:10.1002/cbic.201600702 · Cited by 45
Nagill, R., & Kaur, S. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.01.015 · Cited by 44
Kobayashi, T., Tsukagoshi, S., & Sakurai, Y. (1975) · PubMed · Cited by 42
Moles, E., Galiano, S., Gomes, A., Quiliano, M., Teixeira, C., Aldana, I., Gomes, P., & Fernàndez-Busquets, X. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.08.020 · Cited by 41
Hussain, M., Wilkinson, A., Bramwell, V. W., Christensen, D., & Perrie, Y. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12173 · Cited by 41
Grinstein, S. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00342.2010 · Cited by 39
Ding, Q., Chen, J., Wei, X., Sun, W., Mai, J., Yang, Y., & Xu, Y. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0849-7 · Cited by 38
The ER phagosome connection in the era of membrane contact sites
Nunes, P., & Demaurex, N. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.04.007 · Cited by 38
Albanesi, J. P., Wang, H., Sun, H.-Q., Levine, B., & Yin, H. L. (2015) · Autophagy · doi:10.1080/15548627.2015.1093718 · Cited by 37
Rabenhold, M., Steiniger, F., Fahr, A., Kontermann, R. E., & Rüger, R. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.022 · Cited by 35
Poerio, N., Bugli, F., Taus, F., Santucci, M. B., Rodolfo, C., Cecconi, F., Torelli, R., Varone, F., Inchingolo, R., Majo, F., et al. (2017) · Scientific Reports · doi:10.1038/srep45120 · Cited by 35
Self-citationIbrahim, S. S., Tagami, T., & Ozeki, T. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00914 · Cited by 35
Greco, E., Santucci, M. B., Sali, M., Angelis, F. R. D., Papi, M., Spirito, M. D., Delogu, G., Colizzi, V., & Fraziano, M. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03145.x · Cited by 33
Self-citationMatsui, M., Kohyama, S., Suda, T., Yokoyama, S., Mori, M., Kobayashi, A., Taneichi, M., & Uchida, T. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.100 · Cited by 33
Rifapentine-proliposomes for inhalation: In vitro and In vivo toxicity
Pokharkar, V., Patil-Gadhe, A., Kyadarkunte, A., Pereira, M., Jejurikar, G., Patole, M., & Risbud, A. (2014) · Toxicology International · doi:10.4103/0971-6580.155361 · Cited by 33
Peptides coupled to the surface of a kind of liposome protect infection of influenza viruses
Nagata, T., Toyota, T., Ishigaki, H., Ichihashi, T., Kajino, K., Kashima, Y., Itoh, Y., Mori, M., Oda, H., Yamamura, H., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.010 · Cited by 33
Cell viability modulation through changes of Ca2+-dependent signalling pathways
Wójcik‐Piotrowicz, K., Kaszuba-Zwoińska, J., Rokita, E., & Thor, P. J. (2016) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2016.01.004 · Cited by 33
Mariotti, S., Pardini, M., Gagliardi, M. C., Teloni, R., Giannoni, F., Fraziano, M., Lozupone, F., Meschini, S., & Nisini, R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202900 · Cited by 32
Self-citationIchihashi, T., Satoh, T., Sugimoto, C., & Kajino, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060068 · Cited by 32
Eskandari, F., Talesh, G. A., Parooie, M., Jaafari, M. R., Khamesipour, A., Saberi, Z., Abbasi, A., & Badiee, A. (2014) · Experimental Parasitology · doi:10.1016/j.exppara.2014.08.016 · Cited by 31
Cited by
Design of liposomes as drug delivery system for therapeutic applications
Guimarães, D., Cavaco-Paulo, A., & Nogueira, E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120571 · Cited by 1,196
Type II diabetes mellitus: a review on recent drug based therapeutics.
Padhi, S., Nayak, A. K., & Behera, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110708 · Cited by 726
Materials for oral delivery of proteins and peptides
Brown, T. D., Whitehead, K. A., & Mitragotri, S. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0156-6 · Cited by 520
Overcoming skin barriers through advanced transdermal drug delivery approaches
Phatale, V., Vaiphei, K. K., Jha, S., Patil, D., Agrawal, M., & Alexander, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.025 · Cited by 482
Németh, Z., Csóka, I., Semnani Jazani, R., Sipos, B., Haspel, H., Kozma, G., Kónya, Z., & Dobó, D. G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091798 · Cited by 452
Metadata
- Authors
- Nisini, R., Poerio, N., Mariotti, S., De Santis, F., & Fraziano, M.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-02-05
- Volume
- 9
- Pages
- 155-155
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2794370011
- Cited by
- 296
- References
- 214
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.